While evidence of cancer has been traced to ancient times, many people suspect that there is a relationship between the changes we humans have made to our environment and the growth of cancer into one of the world’s most prevalent and potentially lethal diseases. Since the dawn of the industrial age, human exposure to heavy metals has risen dramatically.

The explosion of new products and materials that followed World War II took heavy metals exposure from the workplace into the home. Not only did workers in more than 50 professions including physicians, dentists, laboratory workers, printers, metalworkers, photographers and artists risk health consequences from on-the-job exposure to mercury, lead and other heavy metals; but consumers were also placed at risk by heavy metals present in common household goods, including paint, tap water, cosmetics, processed foods and amalgam dental fillings.

Chelation therapy is used to rid the body of undesirable substances such as heavy metals, chemical toxins, mineral deposits and fatty plaques. Derived from the Greek word for “claw,” chelation “grabs” the offending substance, encircling the metal or mineral ion and transporting it from the body in the urine or feces.

The synthetic amino acid EDTA (Ethylene Diamine Tetraacetic Acid) was first used in the treatment of lead poisoning in 1948. Intravenous EDTA chelation is now approved by the Food and Drug Administration for treatment for lead poisoning.

The use of chelation therapy gradually spread to the treatment of other heavy metals and conditions, including cardiovascular disease, diabetic arterial disease, vascular disease and cancer. For more information on the use of chelation therapy in cancer treatments, visit our website.